88 related articles for article (PubMed ID: 15325248)
21. Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors.
Michel AD; Xing M; Humphrey PP
Br J Pharmacol; 2001 Apr; 132(7):1501-8. PubMed ID: 11264244
[TBL] [Abstract][Full Text] [Related]
22. Functional and therapeutic importance of purinergic signaling in polycystic kidney disease.
Ilatovskaya DV; Palygin O; Staruschenko A
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1135-F1139. PubMed ID: 27654892
[TBL] [Abstract][Full Text] [Related]
23. Purinergic P2X7 receptors mediate ATP-induced saliva secretion by the mouse submandibular gland.
Nakamoto T; Brown DA; Catalán MA; Gonzalez-Begne M; Romanenko VG; Melvin JE
J Biol Chem; 2009 Feb; 284(8):4815-22. PubMed ID: 19097994
[TBL] [Abstract][Full Text] [Related]
24. Apical P2XR contribute to [Ca2+]i signaling and Isc in mouse renal MCD.
Li L; Lynch IJ; Zheng W; Cash MN; Teng X; Wingo CS; Verlander JW; Xia SL
Biochem Biophys Res Commun; 2007 Aug; 359(3):438-44. PubMed ID: 17560948
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney.
Orellana SA; Sweeney WE; Neff CD; Avner ED
Kidney Int; 1995 Feb; 47(2):490-9. PubMed ID: 7723235
[TBL] [Abstract][Full Text] [Related]
26. The P2X7 ATP receptor in the kidney: a matter of life or death?
Hillman KA; Burnstock G; Unwin RJ
Nephron Exp Nephrol; 2005; 101(1):e24-30. PubMed ID: 15925905
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the P2X7 receptor reduces cystogenesis in PKD.
Chang MY; Lu JK; Tian YC; Chen YC; Hung CC; Huang YH; Chen YH; Wu MS; Yang CW; Cheng YC
J Am Soc Nephrol; 2011 Sep; 22(9):1696-706. PubMed ID: 21636640
[TBL] [Abstract][Full Text] [Related]
28. ATP release into ADPKD cysts via pannexin-1/P2X7 channels decreases ENaC activity.
Arkhipov SN; Pavlov TS
Biochem Biophys Res Commun; 2019 May; 513(1):166-171. PubMed ID: 30952430
[TBL] [Abstract][Full Text] [Related]
29. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons.
Anderson CM; Nedergaard M
Trends Neurosci; 2006 May; 29(5):257-62. PubMed ID: 16564580
[TBL] [Abstract][Full Text] [Related]
30. Knockout of
Arkhipov SN; Potter DL; Geurts AM; Pavlov TS
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1649-F1655. PubMed ID: 31630543
[TBL] [Abstract][Full Text] [Related]
31. Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice.
Zeng F; Miyazawa T; Kloepfer LA; Harris RC
Kidney Int; 2014 Sep; 86(3):538-47. PubMed ID: 24670412
[TBL] [Abstract][Full Text] [Related]
32. Characterization of purinergic receptor expression in ARPKD cystic epithelia.
Palygin O; Ilatovskaya DV; Levchenko V; Klemens CA; Dissanayake L; Williams AM; Pavlov TS; Staruschenko A
Purinergic Signal; 2018 Dec; 14(4):485-497. PubMed ID: 30417216
[TBL] [Abstract][Full Text] [Related]
33. ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys.
Wilson PD; Hovater JS; Casey CC; Fortenberry JA; Schwiebert EM
J Am Soc Nephrol; 1999 Feb; 10(2):218-29. PubMed ID: 10215320
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.
Richards WG; Sweeney WE; Yoder BK; Wilkinson JE; Woychik RP; Avner ED
J Clin Invest; 1998 Mar; 101(5):935-9. PubMed ID: 9486961
[TBL] [Abstract][Full Text] [Related]
35. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor.
Baricordi OR; Melchiorri L; Adinolfi E; Falzoni S; Chiozzi P; Buell G; Di Virgilio F
J Biol Chem; 1999 Nov; 274(47):33206-8. PubMed ID: 10559192
[TBL] [Abstract][Full Text] [Related]
36. Increased YAP Activation Is Associated With Hepatic Cyst Epithelial Cell Proliferation in ARPKD/CHF.
Jiang L; Sun L; Edwards G; Manley M; Wallace DP; Septer S; Manohar C; Pritchard MT; Apte U
Gene Expr; 2017 Nov; 17(4):313-326. PubMed ID: 28915934
[TBL] [Abstract][Full Text] [Related]
37. Attenuated expression of epithelial cell adhesion molecules in murine polycystic kidney disease.
Rocco MV; Neilson EG; Hoyer JR; Ziyadeh FN
Am J Physiol; 1992 Apr; 262(4 Pt 2):F679-86. PubMed ID: 1566881
[TBL] [Abstract][Full Text] [Related]
38. P2X7-mediated chemoprevention of epithelial cancers.
Gorodeski GI
Expert Opin Ther Targets; 2009 Nov; 13(11):1313-32. PubMed ID: 19845494
[TBL] [Abstract][Full Text] [Related]
39. Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse.
Sorenson CM; Padanilam BJ; Hammerman MR
Am J Physiol; 1996 Jul; 271(1 Pt 2):F184-93. PubMed ID: 8760259
[TBL] [Abstract][Full Text] [Related]
40. Autosomal recessive polycystic kidney disease: characterization of human peritoneal and cystic kidney cells in vitro.
Hjelle JT; Waters DC; Golinska BT; Steidley KR; Burmeister V; Caughey R; Ketel B; McCarroll DR; Olsson PJ; Prior RB
Am J Kidney Dis; 1990 Feb; 15(2):123-36. PubMed ID: 2154094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
